Page last updated: 2024-10-16

carnitine and End Stage Liver Disease

carnitine has been researched along with End Stage Liver Disease in 1 studies

End Stage Liver Disease: Final stage of a liver disease when the liver failure is irreversible and LIVER TRANSPLANTATION is needed.

Research Excerpts

ExcerptRelevanceReference
"L-carnitine is potentially beneficial in patients with hepatic encephalopathy (HE)."9.51Effect of L-carnitine on quality of life in covert hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. ( Ahn, SB; Cho, YK; Jeong, JY; Jeong, SW; Jun, DW; Jung, YK; Kim, HS; Kim, HY; Kim, SE; Kim, SG; Lee, TH; Song, DS; Song, MJ; Yoon, EL, 2022)
"L-carnitine is potentially beneficial in patients with hepatic encephalopathy (HE)."5.51Effect of L-carnitine on quality of life in covert hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. ( Ahn, SB; Cho, YK; Jeong, JY; Jeong, SW; Jun, DW; Jung, YK; Kim, HS; Kim, HY; Kim, SE; Kim, SG; Lee, TH; Song, DS; Song, MJ; Yoon, EL, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Yoon, EL1
Ahn, SB1
Jun, DW1
Cho, YK1
Song, DS1
Jeong, JY1
Kim, HY1
Jung, YK1
Song, MJ1
Kim, SE1
Kim, HS1
Jeong, SW1
Kim, SG1
Lee, TH1

Trials

1 trial available for carnitine and End Stage Liver Disease

ArticleYear
Effect of L-carnitine on quality of life in covert hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.
    The Korean journal of internal medicine, 2022, Volume: 37, Issue:4

    Topics: Carnitine; Double-Blind Method; End Stage Liver Disease; Hepatic Encephalopathy; Humans; Liver Cirrh

2022